NASDAQ: ADIL
Adial Pharmaceuticals Inc Stock Ownership - Who owns Adial Pharmaceuticals?

Insider buying vs selling

Have Adial Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ADIL insiders and whales buy or sell their stock.

ADIL Shareholders

What type of owners hold Adial Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cary J. Claiborne6.96%1,520,000$598.88kInsider
William B. Stilley Iii6.39%1,393,920$549.20kInsider
Bankole A. Johnson4.00%872,720$343.85kInsider
James W. Newman Jr.2.01%438,742$172.86kInsider
Joseph Truluck1.21%265,139$104.46kInsider
Robertson H. Gilliland0.50%109,424$43.11kInsider
Geode Capital Management LLC0.32%68,850$27.13kInstitution
Manchester Capital Management LLC0.22%48,097$18.95kInstitution
Blackrock Inc0.13%27,770$10.94kInstitution
Jane Street Group LLC0.11%24,862$9.80kInstitution

1 of 3

ADIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADIL1.08%21.16%
KPRX7.08%92.92%Net Buying
VYNE23.70%76.30%Net SellingNet Selling
RNAZ0.87%99.13%
EVGN1.96%0.00%

Adial Pharmaceuticals Stock Ownership FAQ

Who owns Adial Pharmaceuticals?

Adial Pharmaceuticals (NASDAQ: ADIL) is owned by 1.08% institutional shareholders, 21.16% Adial Pharmaceuticals insiders, and 77.77% retail investors. Cary J. Claiborne is the largest individual Adial Pharmaceuticals shareholder, owning 1.52M shares representing 6.96% of the company. Cary J. Claiborne's Adial Pharmaceuticals shares are currently valued at $598.88k.

If you're new to stock investing, here's how to buy Adial Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.